entity

Toxicity

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Toxicity: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

6Connections
17Hypotheses
3Analyses
0Outgoing
6Incoming
11Experiments
3Debates

No AI portrait yet

Wiki Pages (5)

Knowledge base pages for this entity

RNA Toxicity Pathway

mechanism · 2923 words

Metal Ion Toxicity in Neurodegeneration

mechanism · 1926 words

Protein Oligomerization Toxicity Pathway in Neurodegeneration

mechanism · 1557 words

Validated Hypothesis: TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease

hypothesis · 1001 words

Composite Claim: APOE and Cholesterol Transport Shape Clearance, Lipid Toxicity, and Immune State

convergence_synthesis · 577 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (6)

SourceRelationTypeStr
ESCRT-III depletioncontributes_toprocess0.85
Bispecific Antibodiescausesdrug0.85
Modified Taumediatesbiomarker0.80
domain_interactioncausesstructural_phenotype0.70
non-selective TG2 inhibitioncausesphenotype0.70

Targeting Hypotheses (17)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxic 0.847 neurodegeneration Legacy Pre-Pipeline Hypothesis Import
TBK1-OPTN-p62 selective autophagy failure across ALS, FTD, a 0.776 multi Cross-disease neurodegeneration mechanis
Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Choli 0.769 - Do β-amyloid plaques and neurofibrillary
Selective LXRβ agonists restore ABCA1/ABCG1 expression and A 0.763 neuroscience APOE4-driven lipid metabolism dysregulat
Microglial TREM2 Activation Reduces Amyloid-Associated Neuro 0.710 neurodegeneration Test Preregistration Analysis
C9orf72 repeat RNA and dipeptide-repeat toxicity in ALS/FTD 0.700 neurodegeneration Test
DLK MAPK Pathway Inhibition to Block Tau-Induced Neurotoxici 0.634 neurodegeneration Should microtubule-stabilizing drugs be
Closed-loop optogenetic targeting of PV interneurons to rest 0.633 als -
Subtle NMDAR Inhibition Attenuates Excitotoxicity-Driven Tau 0.620 neurodegeneration Investigate prion-like spreading of tau
Microglial xCT/SLC7A11 Selective Inhibition to Reduce Non-Ce 0.620 - Ferroptosis in ALS and motor neuron dise
Neuropeptide Y (NPY) Co-release from PV Interneurons Modulat 0.585 alzheimers Closed-loop optogenetic targeting PV int
Gut Bacterial Metabolite-AhR Dysregulation Converts SCFA-Def 0.580 neurodegeneration How does gut microbiome dysbiosis contri
Small-Molecule FUS Nuclear Import Correctors Rescue Motor Ne 0.550 neurodegeneration Test Hypothesis Fixtures
TLR2 Recognition of Gut-Derived Fungal and Bacterial D-Alany 0.550 neurodegeneration How does gut microbiome dysbiosis contri
Synaptic NMDAR Subtype Targeting Prevents Excitotoxicity 0.520 neurodegeneration Test Preregistration Analysis
Mitochondrial Dysfunction Increasing Neuronal Vulnerability 0.470 neurodegeneration How does APOE4 mechanistically increase
Amyloid first impairs cholinergic terminals through alpha7 n 0.450 neurodegeneration What determines the temporal sequence of

Mentioning Analyses (3)

Scientific analyses that reference this entity

APOE4 structural biology and therapeutic targeting strategies

neurodegeneration | 2026-04-01 | 0 hypotheses

Protein aggregation cross-seeding across neurodegenerative diseases

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.639

Epigenetic clocks and biological aging in neurodegeneration

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (11)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Gandouling protection against brain injury in Wilson's disease via SIR validation Hepatolenticular degeneration 0.900 0.00 TX mice (Wilson's disease mode proposed N/A
Single nuclei transcriptomic and epigenomic profiling of 84 donors acr gene_expression Alzheimer's disease 0.500 0.00 human extracted N/A
The Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD) integrates n neuropathology Alzheimer's disease 0.500 0.00 human extracted N/A
In late life, NfL demonstrated the strongest association with incident clinical Alzheimer's disease 0.500 0.00 human extracted N/A
Complex gene expression differences were identified, ranging from glob gene_expression Alzheimer's disease 0.500 0.00 post_mortem_brain extracted N/A
A subset of donors with particularly severe cellular and molecular phe clinical Alzheimer's disease 0.500 0.00 human extracted N/A
Midlife hypertension was associated with 0.15-SD faster NfL increase a clinical Alzheimer's disease 0.500 0.00 human extracted N/A
A subset of donors exhibited particularly severe cellular and molecula computational Alzheimer's disease 0.500 0.00 human extracted N/A
Cell type-specific analysis identified early-phase loss of somatostati gene_expression Alzheimer's disease 0.500 0.00 human extracted N/A
Single-cell/multiomics analysis of 84 human post-mortem brains reveale computational Alzheimer's disease 0.500 0.00 human extracted N/A
Temporal analysis of gene expression differences across disease progre gene_expression Alzheimer's disease 0.500 0.00 human extracted N/A

Related Papers (8)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
α7nAChR activation in AT2 cells promotes alveolar regeneration through WNT7B sig [PMID:37410546] Unknown JCI Insight 2023 0
PINK1/PARKIN signalling in neurodegeneration and neuroinflammation. [PMID:33168089] Quinn PMJ, Moreira PI, Ambrósio AF, Alve Acta neuropathologica communic 2020 0
Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresse [PMID:30185628] Unknown Cancer discovery 2019 0
CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents. [PMID:28817303] Gillentine Madelyn A; White Janson J; Gr Journal of child and adolescen 2017 0
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. [PMID:25803835] Unknown Nature neuroscience 2015 0
Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibility. [PMID:25655306] Unknown Am J Med Genet A 2015 0
The human clinical phenotypes of altered CHRNA7 copy number. [PMID:26095975] Unknown Biochem Pharmacol 2015 0
The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. [PMID:25611507] ["Pickrell Alicia M", "Youle Richard J"] Neuron 2015 0

Debates (3)

Multi-agent debates referencing this entity

What are the mechanisms underlying apoe4 structural biology and therapeutic targ

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

What are the mechanisms underlying protein aggregation cross-seeding across neur

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

What are the mechanisms underlying epigenetic clocks and biological aging in neu

closed · Rounds: 4 · Score: 0.88 · 2026-04-01

Related Research

Hypotheses and analyses mentioning Toxicity in their description or question text

C9orf72 repeat RNA and dipeptide-repeat toxicity in ALS/FTD

Score: 0.700 · neurodegeneration · 2026-04-29

C9orf72 hexanucleotide repeat expansion produces repeat RNA foci and RAN-translated dipeptide-repeat proteins that disru

DLK MAPK Pathway Inhibition to Block Tau-Induced Neurotoxicity Without Directly

Score: 0.634 · neurodegeneration · 2026-04-15

## Mechanistic Overview DLK MAPK Pathway Inhibition to Block Tau-Induced Neurotoxicity Without Directly Targeting Tau st

Subtle NMDAR Inhibition Attenuates Excitotoxicity-Driven Tau Release from Hypers

Score: 0.620 · neurodegeneration · 2026-04-22

## Mechanistic Overview Subtle NMDAR Inhibition Attenuates Excitotoxicity-Driven Tau Release from Hypersynchronized Circ

Microglial xCT/SLC7A11 Selective Inhibition to Reduce Non-Cell-Autonomous Glutam

Score: 0.620 · unknown disease · 2026-04-16

**Molecular Mechanism and Rationale** The system xc- transporter, composed of the light chain xCT (SLC7A11) and the hea

Neuropeptide Y (NPY) Co-release from PV Interneurons Modulates Aβ Toxicity

Score: 0.585 · alzheimers · 2026-04-28

PV interneurons co-release NPY, which signals via Y1 receptors on excitatory terminals to suppress glutamate release and

Gut Bacterial Metabolite-AhR Dysregulation Converts SCFA-Deficiency into IDO1-Dr

Score: 0.580 · neurodegeneration · 2026-04-26

Aryl hydrocarbon receptor (AhR), expressed in microglia, astrocytes, and neurons, normally ligates tryptophan catabolite

Small-Molecule FUS Nuclear Import Correctors Rescue Motor Neuron Toxicity

Score: 0.550 · neurodegeneration · 2026-04-26

ALS-linked FUS mutations (P525L, R521C) impair nuclear import via karyopherin-β2 (Transportin-1), causing cytoplasmic ac

TLR2 Recognition of Gut-Derived Fungal and Bacterial D-Alanylated Lipoteichoic A

Score: 0.550 · neurodegeneration · 2026-04-26

Dysbiosis permits overgrowth of SIBO species and opportunistic fungi (Candida albicans, Malassezia) whose cell wall comp

Synaptic NMDAR Subtype Targeting Prevents Excitotoxicity

Score: 0.520 · neurodegeneration · 2026-04-28

Selective GluN2A activation or GluN2B inhibition shifts balance from excitotoxic extrasynaptic signaling toward neuropro

Mitochondrial Dysfunction Increasing Neuronal Vulnerability to TDP-43 Toxicity

Score: 0.470 · neurodegeneration · 2026-04-21

## Mechanistic Overview Mitochondrial Dysfunction Increasing Neuronal Vulnerability to TDP-43 Toxicity starts from the c

Amyloid first impairs cholinergic terminals through alpha7 nicotinic receptor-de

Score: 0.450 · neurodegeneration · 2026-04-25

Soluble amyloid oligomers may injure cholinergic terminals via CHRNA7-linked calcium dysregulation, making cholinergic d